Phase I Open and Monocentric Clinical Trial With Pharmacokinetic and Pharmacodynamic Determination of Intravenous Recombinant Human Erythropoietin in Male Adults
Latest Information Update: 23 Aug 2024
At a glance
- Drugs Epoetin alfa (Primary)
- Indications Anaemia
- Focus Pharmacokinetics
- Acronyms RUBI
- Sponsors Megalabs
- 21 Aug 2024 Planned End Date changed from 1 Dec 2023 to 1 Dec 2024.
- 21 Aug 2024 Planned primary completion date changed from 1 Mar 2023 to 1 Dec 2024.
- 21 Aug 2024 Planned initiation date changed from 1 Jan 2023 to 6 Oct 2024.